News|Articles|October 31, 2024
Pharmatech Insights – Developing a Biosimilar Candidate
Author(s)Pharmatech
A key element of a biosimilar program includes building a development plan to demonstrate comparability between the proposed product and the selected reference product. What steps should be taken to prepare?
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
4
Streamlining Procurement and Inventory Management Leads to Increased Productivity
5
